...
首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Peptidylarginine deiminase: a candidate factor in demyelinating disease.
【24h】

Peptidylarginine deiminase: a candidate factor in demyelinating disease.

机译:肽基精氨酸脱亚氨酶:脱髓鞘疾病的候选因子。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In earlier studies we demonstrated that an increase in the relative amounts of citrullinated myelin basic protein (MBP) was found in multiple sclerosis (Moscarello et al. 1994). To determine the temporal relationship between the citrullinated MBP and peptidylarginine deiminase (PAD), the enzyme responsible for deiminating arginyl residues in proteins, we studied enzyme activity, enzyme protein, PAD mRNA in a spontaneously demyelinating transgenic mouse model and we correlated the amount of PAD with citrullinated MBP. Both PAD protein as measured in an immunoslot blot method and PAD RNA were elevated. In fractionation studies we showed that the increase in PAD enzyme was due to an increase in the PAD found in membrane fractions and not the soluble PAD (PADII). From our data we concluded that up-regulation of myelin-associated PAD was responsible for the increase in citrullinated MBP in our transgenic mice prior to onset of clinical or pathological signs of demyelination. We postulate that a similar mechanism may be responsible for the increase in citrullinated MBP in multiple sclerosis.
机译:在较早的研究中,我们证明在多发性硬化症中发现瓜氨酸化髓鞘碱性蛋白(MBP)的相对量增加(Moscarello et al。1994)。为了确定瓜氨酸化的MBP和负责确定蛋白质中精氨酸残基的肽肽基精氨酸脱亚氨酶(PAD)之间的时间关系,我们研究了自发脱髓鞘的转基因小鼠模型中的酶活性,酶蛋白和PAD mRNA,并关联了PAD的量瓜氨酸化MBP。用免疫印迹法测定的PAD蛋白和PAD RNA均升高。在分级研究中,我们发现PAD酶的增加是由于膜级分中PAD的增加,而不是可溶性PAD(PADII)。根据我们的数据,我们得出结论,在出现脱髓鞘的临床或病理征象之前,髓磷脂相关的PAD的上调是导致我们转基因小鼠中瓜氨酸化MBP升高的原因。我们推测,类似的机制可能是多发性硬化症中瓜氨酸化MBP增加的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号